Ruslan Strogantsev, Ph.D.
- Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Biography
Ruslan Strogantsev is a Specialist at CEDAR. He joins the Knight Cancer Institute after completing his post-doctoral studies in epigenetic mechanisms of genomic imprinting at the University of Cambridge Genetics department, followed by work into the role of DNA damage repair proteins in mouse development and embryonic stem cells at the Babraham Institute in Cambridge, United Kingdom. Strogantsev believes that his knowledge in the areas of development and stem cell field combined with an expertise in wide range of molecular biology techniques will be of great benefit to the CEDAR program and looks forward to new great collaborations. Originally from Novosibirsk in Russia, Ruslan has moved to UK to pursue a BS.c. in Biochemistry, went on to do his Ph.D. in Glasgow, Scotland, and after spending a total of 18 years on the British isles is excited to make Portland, Oregon his new home.
Publications
Publications
Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells
Nature communicationsZFP57 regulation of transposable elements and gene expression within and beyond imprinted domains
Epigenetics and ChromatinQuantitative comparison of DNA methylation assays for biomarker development and clinical applications
Nature biotechnologyTrim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity
CellAllele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression
Genome biologyDNMT1 and AIM1 Imprinting in human placenta revealed through a genome-wide screen for allele-specific DNA methylation
BMC GenomicsHematopoiesis and stem cells
BloodJdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
OncogeneProteins involved in establishment and maintenance of imprinted methylation marks
Briefings in Functional GenomicsThe inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers
Journal of ImmunologyVEZF1 elements mediate protection from DNA methylation
PLoS genetics